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Abstract
Background: Evidence is growing that both short- and long-term physical exercise have the potential to positively
impact on the physiological system related to inflammatory indices, though, such patterns are unknown for pediatric
patients with Inflammatory Bowel Disease (IBD). The aim of the present intervention study was to investigate the
influence of a single bout and chronic moderate-intensity exercise on IBD-related inflammatory indices and exercise
capacity among pediatric individuals with IBD and healthy controls.
Method: Twenty-one pediatric patients with IBD, split into a “remission-group” (IBD-RE; n = 14) and an “active disease
group” (IBD-AD; n = 7), were compared to 23 age matched healthy controls (HC). All participants completed a single
bout of exercise at baseline and an 8-week exercise intervention. Before and after the single bout of exercise
IBD-related inflammatory indices (erythrocyte sedimentation rate (ESR), albumin, C-reactive protein (CRP), cortisol,
hemoglobin, hematocrit, thrombocytes and leukocytes) were assessed.
Results: At baseline, after a single bout of exercise, inflammation (albumin, hemoglobin, erythrocytes, hematocrit and
leukocytes) increased in all three groups IBD-AD, IBD-RE and HC. CRP and thrombocytes were only elevated in IBD-AD
and IBD-RE, compared to HC. After a longer-term exercise intervention, ESR, CRP and thrombocytes significantly
decreased in all groups. The longer-term exercise intervention did not decrease acute immunopathologic responses
after a single bout of exercise, compared to baseline.
Conclusion: Whereas a single bout of exercise increases albumin, erythrocytes and leukocytes, longer-term moderate-
intensity exercise reduced inflammatory markers in pediatric patients with IBD. Children and teenagers with IBD should
be encouraged to engage in regular moderate-intensity exercise activities, as such activities may contribute to
inflammation suppression and improved disease management.
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Background
Inflammatory bowel disease (IBD) is a chronic inflamma-
tion affecting the gastrointestinal tract. It is commonly di-
vided into two forms: Crohn’s disease (CD) and Ulcerative
colitis (UC) [1]. Whilst UC affects the colon, CD can pro-
mote an inflammation in any part of the digestive system
and for both an increase in prevalence and incidence can
be observed [2]. Symptoms can vary from chronic anemia,
abdominal pain, failure to thrive, bloody diarrhea to toxic
megacolon.
The current standard of care for pediatric patients with
IBD includes a combination of pharmacotherapy, surgical
intervention, and/or enteral nutrition [3]. Physical activity
has frequently been suggested as adjuvant therapy option in
the prevention and treatment of a variety of chronic and in-
flammatory diseases [4–6]. In addition to the favorable effect
on physical, psychological/social and cognitive dimensions
[7, 8] physical activity has a beneficial impact on bone min-
eral density, muscle mass, functional capacity [7] and also
seem to have immune modulating potential [9–11].
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Concerning long-term physical activity interventions in
individuals with IBD, several studies [15–22] and four re-
views [7, 12–14] have been published. A limited number
of studies indicate a beneficial effect of physical activity on
the quality of life [15, 18], psychological and physical as-
pects [17] and physiological symptoms [20] for individuals
with IBD. A randomized control trial over a 12-week
intervention reported improvements in constipation
symptoms [20]. Unfortunately, the effectiveness of single
or longer-term exercise has not been well described [15–
22], the processes are poorly understood and limited to
the adult population [12, 23].
With this in mind, the aim of the current study was to
test the immunopathologic response to a single bout of ex-
ercise after a longer-term intervention in children with IBD.
Our research question was, whether the immunopath-
ologic response to a single bout of exercise would be
reduced after a longer-term intervention. We also for-
mulated two hypotheses: First, we expected higher in-
flammatory indices after a single bout of moderate-
intensity exercise among pediatric patients with IBD and
healthy controls, as in other studies [24, 25] higher pro-
inflammatory cytokines in the same setting were de-
scribed. Second, after consulting the literature [12–14]
we expected that a longer-term moderate-intensity phys-
ical activity intervention would favorably impact the in-
flammatory blood markers in pediatric patients with IBD
and healthy controls.
Methods
As previously described [26] in this case-control 8-week
longer-term physical activity exercise intervention study,
patients with IBD were recruited from the University
Children’s Hospital Basel and the children’s hospital
Aarau (Switzerland). Exclusion criteria were the presence
of another chronic disease and/or intake of regular medi-
cation, other than to treat IBD. Patients, who were inter-
ested in participating were asked to bring an aged
matched healthy friend (chronic disease and regular intake
of medication were exclusion criteria) for the healthy con-
trol group (HC). All participants were invited to the hos-
pital to perform a single bout of exercise and an
assessment immediately before and after the physical
intervention. All participants were fully informed about
the aims of the present study, and the voluntary and confi-
dential basis of their participation. Thereafter, written in-
formed consent was signed by participants and their legal
guardians. All data were collected by two trained research
assistants and supervised by a medical doctor.
Procedures
Before and after a single bout (6-min walking test) and
long-term exercises (8 weeks), IBD-related inflammatory
indices (erythrocyte sedimentation rate (ESR), albumin, C-
reactive protein (CRP), cortisol, hemoglobin, hematocrit,
thrombocytes and leukocytes) were assessed, afterwards
anthropometric measures were taken.
The present study was approved by the local ethical
committee (Ethics committee north-west of Switzerland,
EKNZ: 2014:220). Furthermore, the study was conducted
in accordance to the ethical principles laid down in the
Declaration of Helsinki and its later amendments (Trial
registration number: NCT02264275).
Individuals with IBD were subdivided according to the
activity scores of their disease (PUCAI [Paediatric ul-
cerative colitis activity index] and PCDAI [Paediatric
Crohn’s disease activity index]) [27]. Clinical remission
was defined as PUCAI/PCDAI score of 10 and below.
Medical treatment was not changed during the course of
the study (see Table 3).
Tools
Anthropometric dimensions
Height and waist circumference (measured 4 cm above
the navel using a standard anthropometry tape) were ob-
jectively measured to the nearest 0.1 cm. Weight was
taken in kg and BMI (kg/m2) was calculated and com-
pared to reference values established by Taylor et al. [28]
and to the WHO international growth references [29].
Laboratory assessments
Blood samples were obtained using the finger prick tech-
nique to measure inflammatory indices such as CRP [g/
dl], thrombocyte [g/dl] and leukocyte [g/dl] count, as well
as hemoglobin (Hb) [g/dl], albumin, cortisol and erythro-
cyte sedimentation rate [ESR].
Exercise interventions
Single bout of exercise
To assess the effects of a single bout of exercise, a self-
paced, submaximal 6-min walking test (6MWT) was ap-
plied as part of the baseline and follow-up data assessment.
The 6MWT measures the maximal walking distance of the
participants over 6 min [30]. This was chosen as it has
been validated as suitable for pediatric populations with
chronic diseases [31].
Longer-term physical intervention
As described previously [26], the longer-term physical
intervention incorporated an exergame or active video
gameplay. Exergames were selected since they are easily ac-
cessible with adjustable levels of intensity to minimalize
perceived barriers, perceived threads and as an intervention
to facilitate action taking in a safe environment [32–37].
Exergames can elevate energy expenditure to a moderate
or vigorous intensity, metabolically equivalent to a three
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mile per hour treadmill pace [32]. Furthermore, gamifica-
tion techniques and mechanisms enable to achieve goals,
encourage players through rewards and points, while offer-
ing intrinsic motivation in the form of fun.
After the review of various exergames and their inten-
sity levels, we decided to use the Just Dance Kids® and
Sports-Resort® exergame for Nintendo Wii® in the
present study. Just Dance Kids® is a motion-based dan-
cing game offering the player a collection of songs with
accompanied dance choreography. During the songs,
players mirror the dance performance and comments
displayed on the screen and are awarded for their accur-
acy. The Nintendo Wii Sports-Resorts® game allows chil-
dren to participate in a sports game in a virtual world.
Players can choose between sward play, wakeboarding,
frisbee, archery, basketball, table tennis, golf, bowling,
canoeing and cycling. Players can either compete against
the video game or can play against a second player.
Children and adolescents were offered to choose one
of the games and were encouraged to use the exergames
for 30 min, 5 days a week for a total of 8 weeks. Partici-
pant’s parents were asked to monitor the intervention
frequency in a paper diary to keep track of intervention
adherence over the entire intervention period.
Statistical analyses
Anthropometric measures, blood values and physical activ-
ity outcomes by group (IBD-AD, IBD-RE and HC) and
time (baseline vs post-intervention) were tested with
analysis of variance (ANOVA) for repeated measures.
Post-hoc tests after Bonferroni-Holm corrections were
performed to examine differences between and within the
three specific groups. Given the deviation of sphericity,
Greenhouse-Geisser adjusted the degrees of freedom. The
slope of increasing blood markers between pre and post
single bout of exercise was calculated with [(T0 x T1) / 2]
and the area under the curve (AUC), representing total in-
flammation, was calculated with [((T0 x T1) / 2) × 6]. Sig-
nificance level was set at alpha p < .05. All statistics were
performed with SPSS® 25.0 (IBM Corporation, Armonk
NY, USA) for Windows®.
Results
From over fifty patients with IBD, twenty-three agreed to
participate. After 2 drop-outs the study was finished with
twenty-one pediatric patients with IBD (mean age: 13.35
years; females n = 10 [43.5%]): Seven participants (females
n = 2) were in an active disease state (IBD-AD) and 14
(females n = 8) were in remission (IBD-RE) during the
study period. The mean age of the healthy control group
(HC) was 12.38 years (females n = 15 [62.5%]). For further
details regarding the characteristics we refer to Table 1.
Immunopathologic response after a single bout of exercise
at baseline
Table 2 provides an overview of the descriptive and infer-
ential statistics for blood markers before and after a single
exercise bout (6MWT). All results are presented separ-
ately by time (before vs after single bout), groups (IBD-AD
vs. IBD-RE vs. HC), and interaction (group x time).
Albumin (p = .00), hemoglobin (p = .01), erythrocytes
(p = .00), hematocrit (p = .00) and leukocytes (p = .00) in-
creased in all three groups (IBD-AD, IBD-RE and HC).
No significant time effects were observed for ESR, CRP,
cortisol and thrombocytes.
CRP-values were significantly higher in the IBD-AD
and IBD-RE groups as compared to the HC group
(p = .02). Furthermore, thrombocytes were highest in the
IBD-AD group, followed by the IBD-RE group, and low-
est in HC (p = .00). No significant group effects were
found for BSG, albumin, cortisol, hemoglobin, erythro-
cytes, hematocrit and leukocytes.
Concerning interactions (time x group), no significant
results were observed for any of the blood measures,
namely for ESR, albumin, CRP, cortisol, hemoglobin,
erythrocytes, hematocrit, thrombocytes and leukocytes.
Immunopathologic response after longer-term intervention
Table 2 also provides an overview of the descriptive and
inferential statistics for blood markers before and after
the 8-week physical intervention.
Over time, ESR (p = .01), CRP (p = .00) and thrombo-
cytes (p = .02) significantly decreased. No significant time
effects were observed for albumin, cortisol, hemoglobin,
erythrocytes, hematocrit and leukocytes.
Comparing groups, no significant chances were found
for ESR, albumin, CRP, cortisol, hemoglobin, erythro-
cytes, hematocrit, thrombocytes and leukocytes.
Table 1 Sample Characteristics
IBD-AD IBD-RE HC
(n = 7) (n = 14) (n = 23)
Age in years 12.78 ± 3.25 13.64 ± 2.96 12.38 ± 3.23
Female 2 (28.6%) 8 (57.14%) 15 (62.5%)
IBD
Ulcerative colitis 4 5
Crohn’s Disease 3 8
Indeterminate colitis 1
Time since diagnosis 111.54 ± 83.35 124.74 ± 88.19
Height (cm) 153.48 ± 17.53 152.69 ± 12.02 152.26 ± 18.0
Weight (kg) 45.28 ± 15.85 42.79 ± 12.83 44.37 ± 15.75
Weight to height (%) 44.08 ± 3.07 42.94 ± 2.13 42.77 ± 3.49
BMI 18.6 ± 3.37 17.91 ± 2.78 18.36 ± 3.16
Notes: N = 44, IBD-AD = IBD in an active state of the disease, IBD-RE = IBD in
remission, HC = Healthy Control; all data presented in mean ± standard deviation
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Concerning interactions (time x group), significant
effects were observed for ESR (p = .02), CRP (p = .02)
and thrombocytes (p < .001). Post-hoc analyses with
Bonferroni-Holm corrections for p-values revealed
decreased values over time in IBD-AD and IBD-RE,
while values for HC increased. Moreover, no significant
time effects were detected for ESR, albumin, cortisol,
hemoglobin, erythrocytes, hematocrit and leukocytes.
There was no statistically significant change in clinical
disease activity indices before and after the longer-term
intervention, during which the treatment of the IBD was
not changed (Table 3).
Immunopathologic responses to a single bout of exercise
after 8 weeks of physical exercise
Table 2 provides an overview of the descriptive and in-
ferential statistics for increases in slope and area under
the curve (AUC) for in ESR and CRP and before and
after a single exercise bout (6MWT), before and after 8
weeks of physical exercise. All results have been calcu-
lated for slopes and AUCs and are presented separately
by time (before vs after intervention), groups (IBD-AD
vs. IBD-RE vs. HC), and interaction (group x time).
Over time, the AUC for CRP decreased significantly in
IBD-AD and IBD-RE (p < .001). By contrast, no significant
time effects were observed for ESR slope, ESR AUC and
CRP slope. Concerning group effects, no significant results
were observed for either slope or AUC in ESR or CRP.
Concerning interactions (time x group), AUC of CRP
pre-post comparison was significantly different among
the three groups (p = .01): While CRP AUC decreased
among IBD-AD and IBD-RE, it increased among HC.
Discussion
The key findings of the present study were as follows:
After a single bout of exercise, albumin, hemoglobin,
erythrocytes, hematocrit and leukocytes increased in all
three groups (IBD-AD, IBD-RE and HC). CRP and throm-
bocytes were only elevated in IBD-AD and IBD-RE as
compared to HC. After 8 weeks of physical exercise, ESR,
CRP and thrombocytes significantly decreased in all
groups. The intervention did not diminish acute immuno-
pathologic responses after a single bout of exercise.
Following others [24, 25] we expected that a single
bout of exercise would increase leukocyte, thrombocyte
count and CRP in patients with IBD. Data did confirm
Table 3 Characteristics and medication of IBD patients
Patient Age in years Diagnosis Medication PUCAI/PCDAI before
8-week intervention
PUCAI/PCDAI after
8-week intervention
1 14.16 Crohn’s disease Infliximab 5 mg/kg 6-weekly and Azathioprine 100mg/ day 25 15
2 17.08 Crohn’s disease Infliximab 5 mg/kg 6-weekly 30 25
3 11.75 Ulcerative colitis Azathioprine 100mg/day 0 0
4 17.16 Crohn’s disease Ustekinumab 45mg s.c. 8-weekly 5 5
5 13.41 Ulcerative colitis Golimumab 50 mg s.c. every 4-weekly 0 5
6 14.16 Crohn’s disease Mesalazine 2 g/day 0 5
7 13.83 Crohn’s disease Azathioprine 75 mg daily 0 0
8 12.58 Ulcerative colitis Golimumab 50 mg 4-weekly 25 20
9 13.66 Crohn’s disease Infliximab 5 mg/kg 8-weekly
Azathioprine 100mg/day
5 0
10 12.33 Crohn’s disease Infliximab 5 mg/kg 8-weekly 5 0
11 16.33 Crohn’s disease Azathioprine 75 mg/day 0 0
12 17.75 Ulcerative colitis Azathioprine 100mg/day 25 20
13 4.58 Ulcerative colitis Mesalazine 500mg/day 0 0
14 23.16 Ulcerative colitis no treatment at this time 0 0
15 17.33 Crohn’s disease Infliximab 5 mg/kg 7-weekly 20 15
16 7.58 Ulcerative colitis Mesalazine 1 g/day
Prednisone 20 mg/10 mg/day
40 30
17 15.33 Crohn’s disease Infliximab 5 mg/kg 8weekly 5 0
18 14.16 Indeterminate colitis Infliximab 10 mg/kg 6-weekly 0 5
19 3.0 Ulcerative colitis Mesalazine 500mg/day
Prednisone 15 mg/day
15 10
20 10.66 Ulcerative colitis Mesalazine 1 g/ day 0 0
21 10.5 Crohn’s disease no treatment at this point 5 5
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this. In IBD-AD and IBD-RE, CRP and thrombocytes
were elevated after the single bout of exercise, as com-
pared to HC. Leukocytes, albumin, hemoglobin, erythro-
cytes and hematocrit were elevated in all three groups
after a single bout of exercise. Some previous studies re-
ported no significant exacerbation of subjective or ob-
jective disease symptoms [24, 25]. However, Ploeger et
al. [24] observed increasing cytokine levels after 4x15s
bouts of maximal cycle ergometry. Furthermore, several
studies [38, 39] with patients with other chronic diseases
corroborated the increased levels of circulating blood
markers after a (short) single bout of moderate-to-vigor-
ous physical activity.
While the present data do not allow a deeper introspec-
tion into the underlying physiological mechanisms, we
speculate, that the increase in circulating blood markers
could be caused by decreased plasma volume with an ac-
companied concentration effect [39], along with an activa-
tion of myocytes and macrophages with subsequent
upregulation and expression of proinflammatory cyto-
kines, such as CRP [40]. For the leukocytosis, increases in
cardiac output and blood flow might have led to increased
release of leukocytes from the vascular, pulmonary, hep-
atic, and/or splenic reservoirs. Equally important are cate-
cholamines and glucocorticoids, which bind and activate
exercise-responsive leukocytes during and after exercise.
Moreover, exercise increases the HPA axis activity and
causes increased release of cortisol, which again affects
leukocyte trafficking [41]. Further, hemoglobin is activated
in its function as an oxygen carrying pigment of the red
blood cells from lungs to all tissue [42]. Similarly, the in-
creased serum albumin levels indicate an increased need
to maintain the bodies’ fluid balance and supply proteins
needed for growth and tissue repair.
With the second hypothesis we expected that an
8-week physical exercise intervention favorably impacted
the inflammatory blood markers among pediatric pa-
tients with IBD. As expected [12–14], ESR values, CRP
and thrombocytes significantly decreased in all three
groups. However, comparing groups, ESR was still high-
est in IBD-AD, followed by IBD-RE and HC. Concerning
interactions, decreased values for ESR, CRP and throm-
bocytes were observed over time in the IBD-AD and
IBD-RE groups, while values increased among HC.
However, decreased ESR, CRP and thrombocytes are
considered indicators for a diminished inflammation [17,
24]. The current data do not allow a deeper understand-
ing of the underlying physiological mechanisms, and
again, we rely on findings of previous studies.
First, physical activity reduces transient stool time and
therefore reduces the contact time of pathogens with the
gastrointestinal mucus layer and circulatory system [43].
Furthermore, exercise is known to reduce visceral fat
mass, subsequently reduces the release of adipokines and
introduces an anti-inflammatory environment [44]. Bilski
et al. [41] argued that myokines (e.g. IL-6) released during
skeletal muscle contraction in exercise inhibited the re-
lease of pro-inflammatory mediators. Further, IL-6 stimu-
lated the production of anti-inflammatory factors (IL-1
antagonist and IL-10), inhibited pro-inflammatory cyto-
kine (TNF-alpha) [45, 46] and are related to increases in
glucagon-like peptides [7]. In this way, myokines may bal-
ance or counteract the effects of proinflammatory stimuli
in IBD. Myokines may inhibit the release of proinflamma-
tory mediators from the mesenteric white adipose tissue
(mWAT), which is typically deregulated in IBD [43]. The
theory of increased cytokines like IL-6 can be connected
to our inflammation markers CRP and ESR, since the oc-
currence of IL-6 strongly correlates with CRP [45].
Second, Chen and Noble [47] hypothesized that exercise
induced protective heat shock proteins (HSPS) for the regu-
lation of intestinal inflammation and immunity in animal
models. HSPS are known to stabilize denatured proteins,
suppress pro-inflammatory transcription factors and de-
crease the secretion of pro-inflammatory cytokines [47, 48].
With the research question we examined whether the
immunopathologic response to a single bout of exercise
will be reduced after 8 weeks of physical intervention.
Data showed that this was not the case. Longer-term ex-
ercise participation did not protect against short-term
exercise induced changes in circulating cytokines. How-
ever, results confirmed an overall anti-inflammatory ef-
fect due to reduction in total inflammation. In summary,
the current literature, as well as our findings, point to-
wards an anti-inflammatory effect of exercise, but the
exact underlying mechanism remains to be determined.
The strength of the present study is that to the best of
our knowledge, it is the first to investigating the effects
of a longer-lasting physical exercise intervention in a
pediatric group of IBD-patients. Our data supports the
hypothesis that exercising has the potential to contribute
to inflammation suppression and disease management in
pediatric patients with IBD.
On the flip side, several issues warrant against an
overgeneralization. First, the sample size was rather
small. Second, no non-interventional control group was
included; this limited the potential of the study to detect
intervention effects. Third, in this study, active vs. non-
active IBD was in focus, however, the different etiologies
of Crohn’s disease (CD) vs. ulcerative colitis (UC) might
involve different mechanisms and should be investigated
in the future. Fourth, it is conceivable that the pattern of
results might depend on further latent, but unassessed
physiological and psychological variables.
Conclusion
Whereas a single bout of exercise increases albumin,
erythrocytes and leukocytes, moderate-intensity aerobic
Legeret et al. BMC Pediatrics          (2019) 19:297 Page 6 of 8
exercise across 8 consecutive weeks reduced inflamma-
tory markers among pediatric patients with IBD.
Pediatric patients with IBD should be encouraged to en-
gage in regular moderate-intensity exercise activities, as
such activities may contribute to inflammation suppres-
sion and improved disease management.
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